Cost-effectiveness of varicella vaccination of healthcare workers

Vaccine

Volumn 23, Issue 43, 2005, Pages 5064-5072

  Chodick, Gabriel ^a,b   Ashkenazi, Shai ^a,b   Livni, Gilat ^a,b   Lerman, Yehuda ^a,c  

^a TEL AVIV UNIVERSITY   (Israel)

^b SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^c Natl Occup Environ Hlth Inst   (Israel)

Author keywords

Cost effectiveness; Healthcare workers; Vaccine; Varicella

Indexed keywords

CHICKENPOX VACCINE;

ADULT; ANAMNESIS; ARTICLE; CHICKENPOX; COHORT ANALYSIS; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DATA ANALYSIS; DISEASE PREDISPOSITION; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; INJECTION SITE REACTION; ISRAEL; MASS IMMUNIZATION; MEDICAL LITERATURE; NURSE; OCCUPATIONAL HAZARD; PAIN; PHYSICIAN; PRIORITY JOURNAL; PROBABILITY; RASH; SCREENING; SENSITIVITY ANALYSIS; SEROLOGY; STATISTICAL MODEL; VACCINATION; VARICELLA ZOSTER VIRUS;

CHICKENPOX; CHICKENPOX VACCINE; COST OF ILLNESS; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; HEALTH CARE COSTS; HUMANS; IMMUNIZATION PROGRAMS; PERSONNEL, HOSPITAL; VACCINATION;

EID: 24944443355     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.06.004     Document Type: Article

References (47)

1. American Academy of Pediatrics Committee on Infectious Diseases Recommendations for the use of live attenuated varicella vaccine Pediatrics 95 5 1995 791 796
2. American Academy of Pediatrics C.o.I.D. recommendations for the use of live attenuated varicella vaccine Pediatrics 95 1995 791 796
3. Centers for Disease Control Prevention Prevention of varicella: recommendation of the Advisory Committee on Immunization Pediatrics (ACIP) MMWR Morb Mort Wkly Rep 45 1996 1 36
4. M.R. Weitekamp, P. Schan, and R.C. Aber An algorithm for the control of nosocomial varicella-zoster virus infection Am J Infect Control 13 5 1985 193 198
5. L. Saiman Control of varicella-zoster infections in hospitals E. Abrutyn Infection control reference service 1997 WB Saunders Co. Philadelphia, PA 687 693
6. L. Saiman, P. LaRussa, S.P. Steinberg, J. Zhou, K. Baron, and S. Whittier Persistence of immunity to varicella-zoster virus after vaccination of healthcare workers Infect Control Hosp Epidemiol 22 5 2001 279 283
7. A.R. Venkitaraman, and T.J. John Chicken pox outbreak in staff and students of a hospital in the tropics Lancet 2 8290 1982 165
8. N. Thiry, P. Beutels, P. Van Damme, and E. Van Doorslaer Economic evaluations of varicella vaccination programmes: a review of the literature Pharmacoeconomics 21 1 2003 13 38
9. Y. Lerman, G. Chodick, S. Tepper, G. Livni, and S. Ashkenazi Seroepidemiology of varicella-zoster virus antibodies among health-care workers and day-care-centre personnel Epidemiol Infect 132 2004 1135 1138
10. Labor force in health professions, vol. 2004. Jerusalem: Israel Ministry of Health; 2003. p. 6-16.
11. T.A. Lieu, L.J. Finkler, M.E. Sorel, S.B. Black, and H.R. Shinefield Cost-effectiveness of varicella serotesting versus presumptive vaccination of school-age children and adolescents Pediatrics 95 5 1995 632 638
12. A.M. Gray, P. Fenn, J. Weinberg, E. Miller, and A. McGuire An economic analysis of varicella vaccination for health care workers Epidemiol Infect 119 2 1997 209 220
13. Y. Asano Varicella vaccine: the Japanese experience J Infect Dis 174 Suppl. 3 1996 S310 S313
14. Y. Asano, S. Suga, and T. Yoshikawa Experience and reason: twenty-year follow-up of protective immunity of the Oka strain live varicella vaccine Pediatrics 94 4, Part 1 1994 524 526
15. C.E. Johnson, T. Stancin, D. Fattlar, L.P. Rome, and M.L. Kumar A long-term prospective study of varicella vaccine in healthy children Pediatrics 100 5 1997 761 766
16. K. Banz, S. Wagenpfeil, A. Neiss, A. Goertz, U. Staginnus, and J. Vollmar The cost-effectiveness of routine childhood varicella vaccination in Germany Vaccine 21 11-12 2003 1256 1267
17. D.J. Weber, W.A. Rutala, and C. Parham Impact and costs of varicella prevention in a university hospital Am J Public Health 78 1 1988 19 23
18. M. Almuneef, Z.A. Memish, M.E. Abbas, and H.H. Balkhy Screening healthcare workers for varicella-zoster virus: can we trust the history? Infect Control Hosp Epidemiol 25 7 2004 595 598
19. A.M. Santos, E. Ono, L.Y. Weckx, A.P. Coutinho, and M.I. de Moraes-Pinto Varicella zoster antibodies in healthcare workers from two neonatal units in Sao Paulo, Brazil - assessment of a staff varicella policy J Hosp Infect 56 3 2004 228 231
20. A. Josephson, L. Karanfil, and M.E. Gombert Strategies for the management of varicella-susceptible healthcare workers after a known exposure Infect Control Hosp Epidemiol 11 6 1990 309 313
21. J. O'Neill, and J. Buttery Varicella and paediatric staff: current practice and vaccine cost-effectiveness J Hosp Infect 53 2 2003 117 119
22. C.Y. Chong, S.H. Lim, W.Y. Ng, N. Tee, and R.V. Lin Varicella screening and vaccination for healthcare workers at KK Women's and Children's Hospital Ann Acad Med Singapore 33 2 2004 243 247
23. J.A.G. De Juanes, M.A. San-Martin, M. Gonzalez, J. Estebanb, and A. Garcia de Codesa Seroprevalence of varicella antibodies in healthcare workers and health sciences students: reliability of self-reported history of varicella Vaccine 23 2005 1434 1436
24. A. Behrman, D.S. Schmid, A. Crivaro, and B. Watson A cluter of primary varicella cases among healthcare workers with flase-positive varicella zoster virus titers Infect Control Hosp Epidemiol 24 2003 202 206
25. T. Hanslik, P.Y. Boelle, M. Schwarzinger, F. Carrat, K.A. Freedberg, and A.J. Valleron Varicella in French adolescents and adults: individual risk assessment and cost-effectiveness of routine vaccination Vaccine 21 25-26 2003 3614 3622
26. Prevention of varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention MMWR Recomm Rep 45 RR-11 1996 1 36
27. M. Qureshi, S.M. Gordon, B. Yen-Lieberman, and D.G. Litaker Controlling varicella in the healthcare setting: barriers to varicella vaccination among healthcare workers Infect Control Hosp Epidemiol 20 7 1999 516 518
28. M. Vazques, P. LaRussa, and A. Gershon The effectiveness of varicella vaccine in clinical practice N Engl J Med 344 13 2001 955 960
29. M.D. Nettleman, and M. Schmid Controlling varicella in healthcare setting: the cost effectiveness of using varicella vaccine in healthcare workers Infect Control Hosp Epidemiol 18 7 1997 504 508
30. D.B. Mark, M.A. Hlatky, R.M. Califf, C.D. Naylor, K.L. Lee, and P.W. Armstrong Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction N Engl J Med 332 21 1995 1418 1424
31. K.J. Smith, and M.S. Roberts Cost effectiveness of vaccination strategies in adults without a history of chickenpox Am J Med 108 9 2000 723 729
32. J. Gayman A cost-effectiveness model for analyzing two varicella vaccination strategies Am J Health Syst Pharm 55 24, Suppl. 4 1998 S4 S8
33. G.M. Ginsberg, and E. Somekh Cost containment analysis of childhood vaccination against varicella in Israel J Infect 48 2 2004 119 133
34. D. Haiduven, C. Hench, S. Simpkins, K. Scott, and D. Stevens Management of varicella-vaccinated patients and employees exposed to varicella in the healthcare setting Infect Control Hosp Epidemiol 24 7 2003 538 543
35. S.R. Preblud, W.A. Orenstein, J.P. Koplan, K.J. Bart, and A.R. Hinman A benefit-cost analysis of a childhood varicella vaccination programme Postgrad Med J 61 Suppl. 4 1985 17 22
36. J. Faoagali, and D. Darcy Chickenpox outbreak among the staff of a large, urban adult hospital: costs of monitoring and control Am J Infect Control 23 1995 247 250
37. Israel Central Bureau of Statistics. Jerusalem: Wages and Employment Monthly Statistics; 2005.
38. Y. Avrahami-Heller, D. Cohen, N. Orr, R. Slepon, I. Ashkenazi, and Y. Danon Immunity to varicella zoster virus in young Israeli adults Israel Med Assoc J 2000 2 2000 196 199
39. P.M. Ndumbe, J.E. Cradock-Watson, S. MacQueen, H. Dunn, H. Holzel, and F. Andre Immunisation of nurses with a live varicella vaccine Lancet 18 1985 1144 1147
40. E. Wasmuth, and W. Miller Sensitive enzyme-linked immunosorbent assay for antibody to varicella-zoster virus using purified VZV glycoprotein antigen J Med Virol 32 1990 189 193
41. P.A. Brunell, and D. Wood Varicella serological status of healthcare workers as a guide to whom to test or immunize Infect Control Hosp Epidemiol 20 5 1999 355 357
42. L. Salleras, A. Dominguez, J. Vidal, P. Plans, M. Salleras, and J.L. Taberner Seroepidemiology of varicella-zoster virus infection in Catalonia (Spain). Rationale for universal vaccination programmes Vaccine 19 2-3 2000 183 188
43. J. Gallagher, B. Quaid, and B. Cryan Susceptibility to varicella zoster virus infection in health care workers Occup Med (Lond) 46 4 1996 289 292
44. G. Vandersmissen, G. Moens, R. Vranckx, A. de Schryver, and P. Jacques Occupational risk of infection by varicella zoster virus in Belgian healthcare workers: a seroprevalence study Occup Environ Med 57 9 2000 621 626
45. J.H.B. Passwell, Y. Levi, R. Ramon, N. Friedman, and L. Lerner-Geva Use of a computerized database to study the effectiveness of an attenuated varicella vaccine Pediatr Infect Dis J 23 2004 221 226
46. American Academy of Pediatrics Committee on Infectious Diseases Varicella vaccine update Pediatrics 105 1, Part 1 2000 136 141
47. S. Lolekha, W. Tanthiphabha, P. Sornchai, P. Kosuwan, S. Sutra, and B. Warachit Effect of climatic factors and population density on varicella zoster virus epidemiology within a tropical country Am J Trop Med Hyg 64 3-4 2001 131 136